البلد: أستراليا
اللغة: الإنجليزية
المصدر: Department of Health (Therapeutic Goods Administration)
triamcinolone acetonide, Quantity: 10 mg/mL
Aspen Pharma Pty Ltd
Injection, suspension
Excipient Ingredients: carmellose sodium; polysorbate 80; benzyl alcohol; sodium chloride; water for injections; sodium hydroxide; hydrochloric acid
Intraarticular, Intradermal, Intrasynovial
5 x 1mL
Medicine Registered
(S4) Prescription Only Medicine
Intra-Articular: Kenacort-A 10 Injection (Sterile Triamcinolone Acetonide Suspension USP) is indicated for intra-articular or intrasynovial administration, and for injections into tendon sheaths, as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Synovitis of osteoarthritis, rheumatoid arthritis, acute and subacute bursitis, acute gouty arthritis, epicondylitis, acute non-specific tenosynovitis, post-traumatic osteoarthritis. Intradermal: Intralesional administration of Kenacort-A 10 Injection is indicated for the treatment of Keloids, discoid lupus erythermatous, necrobiosis lipoidica diabeticorum, alopecia areata and localised hypertrophic, infiltrated, inflammatory lesions of: lichen planus, psoriatic plaques, granuloma annulare, and lichen simplex chronicus ( neurodermatitis), Kenacort-A 10 Injection also may be useful in cystic tumours of an aponeurosis or tendon ( ganglia).
Visual Identification: Opaque white suspension; Container Type: Ampoule; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius
Registered
1991-09-30
KENACORT ® -A 10 – Consumer Medicine Information Page 1 of 3 KENACORT ® -A 10 _triamcinolone acetonide _ CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about KENACORT-A 10. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking KENACORT-A 10 against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT KENACORT-A 10 IS USED FOR _ _ KENACORT-A 10 is a synthetic corticosteroid containing triamcinolone acetonide as the active ingredient. It is used to treat painful muscles, joints or tendons by injecting directly into the painful site. KENACORT-A 10 can also be used to treat inflammatory skin lesions, psoriatic plaques & hair loss by injecting directly into the lesion or by sub-cutaneous injection. KENACORT-A 10 suppresses inflammation and swelling and relieves pain. It does not cure the underlying problem. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY KENACORT-A 10 HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another purpose. This medicine is available only with a doctor’s prescription. KENACORT-A 10 is not suitable for intravenous, intramuscular or intraocular use. KENACORT-A 10 is not suitable for injection into the nasal turbinates or intralesional injection about the head. KENACORT-A 10 is not recommended for use in children under the age of six. KENACORT-A 10 is not for use in newborn or premature infants. KENACORT-A 10 is a long- acting preparation and is not suitable for use in acute situations. BEFORE YOU ARE GIVEN IT _WHEN YOU MUST NOT BE GIVEN IT _ _ _ DO NOT USE KENACORT-A 10_ _ IF YOU HAVE AN ALLERGY TO TRIAMCINOLONE ACETONIDE OR TO ANY OF THE INGREDIENTS LISTED AT THE END OF THIS LEAFLET. Symptoms of an allergic reaction may include: اقرأ الوثيقة كاملة
1 AUSTRALIAN PRODUCT INFORMATION KENACORT -A 10 (STERILE TRIAMCINOLONE ACETONIDE SUSPENSION USP) 10 MG/1 ML INJECTION AMPOULE FOR INTRA-ARTICULAR, INTRASYNOVIAL OR INTRADERMAL USE (NOT FOR INTRAVENOUS OR INTRAMUSCULAR USE) 1 NAME OF THE MEDICINE Triamcinolone acetonide. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 mL of the sterile, aqueous suspension provides 10 mg of triamcinolone acetonide. For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM Kenacort-A 10 is a sterile, aqueous opaque white suspension. The pH is adjusted using sodium hydroxide and/or hydrochloric acid. At the time of manufacture, the air in the container is replaced by nitrogen. Kenacort-A 10 is suitable for intradermal, intra-articular and intrasynovial injection. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS INTRA-ARTICULAR: Kenacort-A 10 Injection is indicated for intra-articular or intrasynovial administration, and for injections into tendon sheaths, as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: synovitis of osteoarthritis, rheumatoid arthritis, acute and subacute bursitis, acute gouty arthritis, epicondylitis, acute nonspecific tenosynovitis, post-traumatic osteoarthritis. INTRADERMAL: Intralesional administration of Kenacort-A 10 Injection is indicated for the treatment of keloids, discoid lupus erythematous, necrobiosis lipoidica diabeticorum, alopecia areata and localised hypertrophic, infiltrated, inflammatory lesions of: lichen planus, psoriatic plaques, granuloma annulare, and lichen simplex chronicus (neurodermatitis), Kenacort-A 10 Injection also may be useful in cystic tumours of an aponeurosis or tendon (ganglia). 4.2 D OSE AND METHOD OF ADMINISTRATION This preparation contains benzyl alcohol. Not for use in newborn or premature infants (see section 4.4 - PAEDIATRIC USE) GENERAL: 2 The initial dose should be maintained or adjusted until a satisfactory response is noted. If after a reasonable period of time t اقرأ الوثيقة كاملة